|
|
| Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help |
|
Health Affairs, 25, no. 5 (2006):
1291-1301
doi: 10.1377/hlthaff.25.5.1291 © 2006 by Project HOPE |
|
 |
|||||||||||||||
| ||||||||||||||||||||
The Market For Follow-On Biologics: How Will It Evolve?
Grabowski
et al.
Health Affairs
25, no. 5 (2006): 1291
Online Appendix
This Data Supplement consists of supplemental material that, because of space constraints, was not included with the published paper by Henry Grabowski, Iain Cockburn, and Genia Long, "The Market for Follow-On Biologics: How Will It Evolve?"
DISCLAIMER: This material is presented to supplement the published paper. Although it was part of the manuscript that was subjected to the scrutiny of external reviewers, it has not been edited or formatted by the editors of Health Affairs; the authors are solely responsible for any errors herein.
Files in this Data Supplement:
| Home | | | Current Issue | | | Archives | | | Topic Collections | | | Search | | | Blog | | | Subscribe | | | Contact Us | | | Help |
|
© 2001-2009 Project
HOPE–The People-to-People Organization |
||||||||||||||||